Adhera Therapeutics, Inc. Interest Expense
Adhera Therapeutics, Inc. reported Interest Expense of $31.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-18.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2020-11-18
- Adhera Therapeutics, Inc. interest expense for the quarter ending 2020-09-30 was $31.00K, a 78.91% decline year-over-year.
- Adhera Therapeutics, Inc. interest expense for the quarter ending 2020-06-30 was $35.00K.
- Adhera Therapeutics, Inc. interest expense for the quarter ending 2020-03-31 was $20.00K.
- Adhera Therapeutics, Inc. interest expense for the quarter ending 2019-12-31 was $534.00K.
- Adhera Therapeutics, Inc. interest expense for fiscal 2019 was $682.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2020-09-30 | $31.00K 10-Q · filed 2020-11-18 | $66.00K derived: sum of 2 quarters · filed 2020-11-18 | $86.00K 10-Q · filed 2020-11-18 | $620.00K derived: sum of 4 quarters · filed 2020-11-18 |
| 2020-06-30 | $35.00K 10-Q · filed 2020-08-19 | $55.00K 10-Q · filed 2020-08-19 | $589.00K derived: sum of 3 quarters · filed 2020-08-19 | $736.00K derived: sum of 4 quarters · filed 2020-08-19 |
| 2020-03-31 | $20.00K 10-Q · filed 2020-07-06 | $554.00K derived: sum of 2 quarters · filed 2020-07-06 | $701.00K derived: sum of 3 quarters · filed 2020-07-06 | |
| 2019-12-31 | $534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $681.00K derived: sum of 2 quarters · filed 2020-04-14 | $682.00K 10-K · filed 2020-04-14 | |
| 2019-09-30 | $147.00K 10-Q · filed 2019-11-19 | $148.00K 10-Q · filed 2019-11-19 | ||
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-14 | |||
| 2014-03-31 | $1.00M 10-Q · filed 2014-11-14 |